Safety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patients

Chandrashekar, Byalakere Shivanna; Varsha, Danda Venkatesh; Vasanth, Vani; Jagadish, P; Madura, C; Rajashekar, Maragowdanahalli Lingegowda

doi:10.1111/ijd.12544

Cited by 38 publications

(44 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Laser light penetration is decreased in more darkly pigmented skin. Higher fluences and longer wavelengths are required to produce similar clinical effects in darker skin types but should be administered with care to prevent side‐effects caused by higher absorption of the pigmented epidermis . In darker phototypes we recommend the combined use of chilled contact gel, ice, sapphire chilled tip, cryogen spray delivered by dynamic cooling device or external air cooling to preserve the epidermis and prevent pigmentary complications.…”

Section: Treatment Principlesmentioning

confidence: 99%

“…30,33,34 We recommend against avoidance of laser treatment in patients who are on or have recently stopped using oral isotretinoin (GRADE 2C). [35][36][37]…”

Section: Qualification Of Providers Of Laser And/or Ipl Treatmentmentioning

confidence: 99%

“…6 Recent clinical studies showed that invasive acne scar treatments and laser procedures in patients on oral isotretinoin bring no additional risks and that the drug does not delay wound healing. [35][36][37] Disease-related measurements and reporting standards 30,34 Recommendation 4: We recommend the use of clinical (depending on the disorder treated) and photographic outcome measurements to evaluate the primary outcome of laser/IPL procedures (GRADE 1A).…”

Section: Medical History and Clinical Examinationmentioning

confidence: 99%

See 2 more Smart Citations

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Adamič¹,

Pavlović

Rubin

et al. 2015

Acad Dermatol Venereol

View full text Add to dashboard Cite

Aim Lasers and non-coherent intense pulse light sources (IPLS) are based on the principle of selective photothermolysis and can be used for the treatment of many vascular skin lesions. A variety of lasers has been developed for the treatment of congenital and acquired vascular lesions which incorporate these concepts into their design. Although laser and light sources are very popular due to their non-invasive nature, caution should be considered by practitioners and patients to avoid permanent side-effects. The aim of these guidelines is to give evidence-based recommendations for the use of lasers and IPLS in the treatment of vascular lesions. Results Lasers and IPLS are very useful and sometimes the only available method to treat various vascular lesions. It is of a paramount importance that the type of laser or IPLS and their specific parameters are adapted to the indication but also that the treating physician is familiar with the device to be used. The crucial issue in treating vascular lesions is to recognize the immediate end-point after laser treatment. This is the single most important factor to ensure both the efficacy of the treatment and avoidance of serious side-effects. Methods Conflicts of interestNone declared. Funding sourceNone.Since the publication of previous European Society of Laser Dermatology (ESLD) guidelines in 2007, there have been significant advances in the field of laser treatment of common vascular lesions.1 These guidelines have been updated by the Consensus Panel under the auspices of the ESLD. Methodology, search strategy and recommendation formulation are described in Appendix II. A brief overview of vascular lasersStandard vascular lasers include pulsed dye lasers (585 and 595 nm), and KTP-lasers (532 nm), followed by longer wavelength lasers such as alexandrite lasers (755 nm), diode lasers (800-900 nm) and millisecond Nd:YAG lasers (1064 nm). New developments include a non-uniform pulse sequence or a dual-wavelength modality (combined dual wavelength 595 and 1064 nm-pulsed dye and Nd:YAG laser) and microsecond Nd: YAG lasers. [2][3][4][5][6] Even fractional photothermolysis has begun to be used for selected vascular lesions. Lasers' and intense pulse light sources (IPLS) effects are based on the principle of selective photothermolysis. In general, they deliver a precisely graded aliquot of energy to a defined area of the skin in a reproducible, standardized manner that almost always involves addition or evacuation of heat. The greatestThe first two authors have contributed equally to the manuscript.

show abstract

Section: Treatment Principlesmentioning

confidence: 99%

“…30,33,34 We recommend against avoidance of laser treatment in patients who are on or have recently stopped using oral isotretinoin (GRADE 2C). [35][36][37]…”

Section: Qualification Of Providers Of Laser And/or Ipl Treatmentmentioning

confidence: 99%

Section: Medical History and Clinical Examinationmentioning

confidence: 99%

See 1 more Smart Citation

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Adamič¹,

Pavlović

Rubin

et al. 2015

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…Acne scarring can be psychologically detrimental, and withholding potentially effective treatments such as laser resurfacing during and after isotretinoin therapy can negatively impact a patient's quality of life. More recent retrospective cohort studies have challenged this current recommendation and suggested that laser resurfacing (ablative and non‐ablative) may be safe for acne scarring when conducted during and/or within 1–3 months of isotretinoin treatment . However, to the authors’ knowledge there are no randomized split‐face controlled trials that have addressed this issue.…”

Section: Introductionmentioning

confidence: 98%

Safety of non‐ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: A randomized split‐face controlled trial

et al. 2017

View full text Add to dashboard Cite

show abstract

“…74 Notably, there were no differences between the two groups with regard to adverse outcomes, with no development of keloids, atypical scarring, or delayed wound healing following laser therapy. No complications were seen in 35 patients taking isotretinoin 10 mg/kg daily for at least one month prior to a mean of 3.1 sessions with 1,550 nm erbium-doped fiber laser therapy.…”

mentioning

confidence: 88%

Update on the Management of Rosacea

Weinkle

Doktor

Emer

2015

Plastic Surgical Nursing

View full text Add to dashboard Cite

Abstract:Refining diagnostic criteria has identified key characteristics differentiating rosacea, a chronic skin disorder, from other common cutaneous inflammatory conditions. The current classification system developed by the National Rosacea Society Expert Committee consists of erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes. Each subtype stands as a unique entity among a spectrum, with characteristic symptoms and physical findings, along with an intricate pathophysiology. The main treatment modalities for rosacea include topical, systemic, laser, and light therapies. Topical brimonidine tartrate gel and calcineurin inhibitors are at the forefront of topical therapies, alone or in combination with traditional therapies such as topical metronidazole or azelaic acid and oral tetracyclines or isotretinoin. Vascular laser and intense pulsed light therapies are beneficial for the erythema and telangiectasia, as well as the symptoms (itching, burning, pain, stinging, swelling) of rosacea. Injectable botulinum toxin, topical ivermectin, and microsecond long-pulsed neodymium-yttrium aluminum garnet laser are emerging therapies that may prove to be extremely beneficial in the future. Once a debilitating disorder, rosacea has become a well known and manageable entity in the setting of numerous emerging therapeutic options. Herein, we describe the treatments currently available and give our opinions regarding emerging and combination therapies.

show abstract

Safety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patients

Abstract: Isotretinoin does not appear to delay wound healing, and hence invasive procedures can be considered on patients on oral isotretinoin without any compromise on the outcome.

Cited by 38 publications

References 15 publications

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Guidelines of care for vascular lasers and intense pulse light sources from the European Society for Laser Dermatology

Safety of non‐ablative fractional laser for acne scars within 1 month after treatment with oral isotretinoin: A randomized split‐face controlled trial

Update on the Management of Rosacea

Contact Info

Product

Resources

About